{"id":"W3215143226","doi":"10.1038/s41416-021-01608-2","title":"Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients","year":2021,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Royal Victoria Hospital; Dalhousie University; University of Toronto; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Vancouver General Hospital; CancerCare Manitoba","funders":"Karyopharm Therapeutics; American Society of Clinical Oncology","keywords":"Carfilzomib; Medicine; Refractory (planetary science); Dexamethasone; Adverse effect; Internal medicine; Nausea; Multiple myeloma; Oncology; Gastroenterology; Lenalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002709371,0.0001775398,0.0005921116,0.0001566656,0.00007630673,0.00006831884,0.00009920318,0.0001152714,0.0002463977],"category_scores_gemma":[0.0008791583,0.0001822383,0.0001358821,0.0002935771,0.00008703311,0.0002552439,0.00007279193,0.0005822914,0.00000541358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003568549,"about_ca_system_score_gemma":0.0006757067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002338941,"about_ca_topic_score_gemma":0.004822416,"domain_scores_codex":[0.9979371,0.0001200059,0.0005857262,0.0002860947,0.0006470123,0.000424013],"domain_scores_gemma":[0.9981313,0.00018141,0.0002442844,0.0001549217,0.0008485847,0.0004394434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005840106,0.0005143417,0.6410344,0.0000961518,0.0001987169,0.005169254,0.0001463381,0.00001302721,0.003850739,4.289733e-7,0.001012476,0.3473801],"study_design_scores_gemma":[0.01715371,0.0003571227,0.9676281,0.001384929,0.00008522591,0.001117394,0.0001836785,0.0002131631,0.004115947,0.00001129546,0.007586127,0.0001633646],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757092,0.02295632,0.00002694238,0.0003531323,0.0002715633,0.0002465914,0.0001100281,0.000007477396,0.0003187496],"genre_scores_gemma":[0.9860635,0.01056901,0.002015567,0.0002719616,0.0003106049,0.00002017267,0.00002830966,0.00003506498,0.0006858095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3472168,"threshold_uncertainty_score":0.7431462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01664781410360318,"score_gpt":0.305547617937828,"score_spread":0.2888998038342249,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}